S
EVH icon

SignatureFD’s Evolent Health EVH Stock Holding History

SignatureFD’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$60.8K Buy
26,646
+15,744
+144% +$49.9K ﹤0.01% 1613
2025
Q4 		$43.6K Buy
10,902
+2,342
+27% +$13K ﹤0.01% 1731
2025
Q3 		$72.4K Sell
8,560
-2,609
-23% -$25.3K ﹤0.01% 1448
2025
Q2 		$126K Buy
11,169
+4,126
+59% +$37.9K ﹤0.01% 1134
2025
Q1 		$66.7K Buy
7,043
+5,636
+401% +$56.9K ﹤0.01% 1419
2024
Q4 		$15.8K Buy
1,407
+1,316
+1,446% +$23.1K ﹤0.01% 2175
2024
Q3 		$2.57K Sell
91
-187
-67% -$4.82K ﹤0.01% 2768
2024
Q2 		$5.32K Sell
278
-1,180
-81% -$30.1K ﹤0.01% 2491
2024
Q1 		$47.8K Buy
1,458
+13
+0.9% +$415 ﹤0.01% 1584
2023
Q4 		$47.7K Buy
1,445
+1,353
+1,471% +$38.3K ﹤0.01% 1494
2023
Q3 		$2.5K Buy
92
+58
+171% +$1.61K ﹤0.01% 2719
2023
Q2 		$1.03K Sell
34
-35
-51% -$1.13K ﹤0.01% 2965
2023
Q1 		$2.24K Sell
69
-460
-87% -$14.5K ﹤0.01% 2769
2022
Q4 		$14.9K Sell
529
-192
-27% -$5.5K ﹤0.01% 1947
2022
Q3 		$26K Buy
721
+41
+6% +$1.44K ﹤0.01% 1610
2022
Q2 		$21K Buy
680
+97
+17% +$2.83K ﹤0.01% 1739
2022
Q1 		$19K Sell
583
-1,144
-66% -$30K ﹤0.01% 1852
2021
Q4 		$48K Buy
1,727
+32
+2% +$918 ﹤0.01% 1358
2021
Q3 		$53K Hold
1,695
– – ﹤0.01% 1269
2021
Q2 		$36K Buy
1,695
+1,200
+242% +$24K ﹤0.01% 1431
2021
Q1 		$10K Buy
+495
New +$9.41K ﹤0.01% 1850

Other funds holding EVH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $138M AUM 61.96% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SignatureFD's EVH Position: Q1 2026 in Review

SignatureFD increased its Evolent Health (EVH) stake by 144% in Q1 2026, buying an estimated $49.9K and bringing the position to 26,646 shares worth $60.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1613.

SignatureFD first reported a position in EVH in Q1 2021 and has held it in 21 quarters since. The position peaked at $126K in Q2 2025. 191 funds tracked by Wall St. Rank hold EVH as of Q1 2026.

  • SignatureFD held 26,646 shares of Evolent Health worth $60.8K as of Q1 2026.
  • SignatureFD bought 15,744 Evolent Health shares in Q1 2026, an estimated $49.9K.
  • Evolent Health made up ﹤0.01% of SignatureFD's portfolio in Q1 2026, its #1613 holding.
  • SignatureFD first reported a position in Evolent Health in Q1 2021 and has held it in 21 quarters since.
  • SignatureFD's Evolent Health position peaked at $126K in Q2 2025.
  • 191 funds tracked by Wall St. Rank held Evolent Health as of Q1 2026.

Based on SignatureFD's 13F filing for Q1 2026, filed 7 Apr 2026.